Literature DB >> 10430506

Genetic variability at the amyloid-beta precursor protein locus may contribute to the risk of late-onset Alzheimer's disease.

F Wavrant-De Vrièze1, R Crook, P Holmans, P Kehoe, M J Owen, J Williams, K Roehl, D K Lahiri, S Shears, J Booth, W Wu, A Goate, M C Chartier-Harlin, J Hardy, J Pérez-Tur.   

Abstract

In a series of sibpairs with late onset Alzheimer's disease, we have examined the segregation of the loci involved in the early onset, autosomal dominant form of the disorder by using flanking microsatellite repeat markers: thus we have used APP-PCR3 and D21S210 to examine the segregation of the amyloid-beta precursor protein (APP) gene, the markers DI 4S77 and D14S284 to examine the segregation of the presenilin 1 (PSI) gene and the markers D1S227, D1S249 and D1S419 to examine the segregation of presenilin 2 (PS2). We carried out our analyses on the whole dataset of 291 affected sibpairs, and on subsets comprising those sibpairs in which neither had an apolipoprotein E4 allele (65 affected sibpairs) and those in which both had an apolipoprotein E4 allele (165 affected sibpairs). We used the programs SPLINK to generate allele frequencies and MAPMAKER/SIBS to analyze our results. We examined the segregation of the markers D19S908 and D19S918 that are close to the apolipoprotein E (ApoE) gene as a positive control to assess whether the methods we are employing have the capability to identify known loci. The sibpair approach to the identification of genetic risk loci is relatively insensitive as indicated by the failure of the ApoE locus to reach statistical significance (P = 0.06). Nevertheless, these data suggest that neither the PS1 nor the PS2 gene is a major locus for late-onset AD, but that the APP gene cannot be ruled out as a risk locus in those sibships without an E4 allele (P = 0.014). The possibility that APP is indeed a locus for late onset disease will need confirmation in other series of familial cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430506     DOI: 10.1016/s0304-3940(99)00417-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.

Authors:  Joseph H Lee; Sandra Barral; Rong Cheng; Inara Chacon; Vincent Santana; Jennifer Williamson; Rafael Lantigua; Martin Medrano; Ivonne Z Jimenez-Velazquez; Yaakov Stern; Benjamin Tycko; Ekaterina Rogaeva; Yosuke Wakutani; Toshitaka Kawarai; Peter St George-Hyslop; Richard Mayeux
Journal:  Neurogenetics       Date:  2007-10-17       Impact factor: 2.660

2.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

Authors:  Jessie Theuns; Nathalie Brouwers; Sebastiaan Engelborghs; Kristel Sleegers; Veerle Bogaerts; Ellen Corsmit; Tim De Pooter; Cornelia M van Duijn; Peter P De Deyn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2006-04-10       Impact factor: 11.025

3.  The amyloid precursor protein locus and very-late-onset Alzheimer disease.

Authors:  J M Olson; K A Goddard; D M Dudek
Journal:  Am J Hum Genet       Date:  2001-08-07       Impact factor: 11.025

4.  The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain.

Authors:  J C Lambert; D M Mann; J M Harris; M C Chartier-Harlin; A Cumming; J Coates; H Lemmon; D StClair; T Iwatsubo; C Lendon
Journal:  J Med Genet       Date:  2001-06       Impact factor: 6.318

Review 5.  The relationship between amyloid and tau.

Authors:  John Hardy
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

6.  APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.

Authors:  Terhi Peuralinna; Maarit Tanskanen; Mira Mäkelä; Tuomo Polvikoski; Anders Paetau; Hannu Kalimo; Raimo Sulkava; John Hardy; Shiao-Lin Lai; Sampath Arepalli; Dena Hernandez; Bryan J Traynor; Andrew Singleton; Pentti J Tienari; Liisa Myllykangas
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.

Authors:  Juliet A Moncaster; Roberto Pineda; Robert D Moir; Suqian Lu; Mark A Burton; Joy G Ghosh; Maria Ericsson; Stephanie J Soscia; Anca Mocofanescu; Rebecca D Folkerth; Richard M Robb; Jer R Kuszak; John I Clark; Rudolph E Tanzi; David G Hunter; Lee E Goldstein
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review.

Authors:  Melissa E Petersen; Sid E O'Bryant
Journal:  Dev Neurobiol       Date:  2019-09-03       Impact factor: 3.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.